Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarceva in advanced non-small cell lung cancer
NCT01066884Phase 4Completed
- Sponsor
- Roche
- Start
- Apr 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by Roche. Started Apr 2009; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01066884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01066884.